VistaGen Is An Interesting Opportunity, Following Allergan's Anti-Depressant Investment In Naurex Seeking Alpha, 30 Jul 2016 In 2015, Allergan (NYSE: AGN ) bought out Naurex, a private clinical stage company developing a novel antidepressant, for over…